CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION recall
FDA recall D-0768-2026 · initiated Jul 30, 2026
Heritage Pharmaceuticals Inc recalled CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION in Jul 2026 — an FDA Class II recall (D-0768-2026) because Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Details
- Product
- CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
- Recalling company
- Heritage Pharms Inc
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide within the U.S
- Initiated
- Jul 30, 2026
- FDA report date
- Aug 19, 2026
Frequently asked
- Was CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION recalled?
- Heritage Pharmaceuticals Inc recalled CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION in Jul 2026 — an FDA Class II recall (D-0768-2026) because Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION recalled?
- Per the FDA enforcement record, the reason for recall D-0768-2026 was: Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
- Is a recalled CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION are affected?
- Distributed: Nationwide within the U.S. The recall covers these lots — Lot #: 2411550, Exp. 2026/NOV.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0768-2026.